Understanding GW-501516

One of the most controversial substances that hit the pharmaceutical world is gw-501516. In 1992, research collaboration was initiated between GlaxoSmithKline (GSK) and Ligand Pharmaceuticals to discover the truth regarding the claims being associated with this substance. Gw-501516 is a Peroxisome proliferator-activated receptors-delta or PPARDs receptor agonists. An agonist in simpler terms is a substance […]